Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human Estrogen Receptor α Antagonists. Part 1: 3-D QSAR-Driven Rational Design of Innovative Coumarin-Related Antiestrogens as Breast Cancer Suppressants through Structure-Based and Ligand-Based Studies.
Mihović N, Tomašević N, Matić S, Mitrović MM, Kostić DA, Sabatino M, Antonini L, Ragno R, Mladenović M. Mihović N, et al. Among authors: antonini l. J Chem Inf Model. 2021 Oct 25;61(10):5028-5053. doi: 10.1021/acs.jcim.1c00530. Epub 2021 Oct 14. J Chem Inf Model. 2021. PMID: 34648283
Machine Learning Data Augmentation as a Tool to Enhance Quantitative Composition-Activity Relationships of Complex Mixtures. A New Application to Dissect the Role of Main Chemical Components in Bioactive Essential Oils.
Ragno A, Baldisserotto A, Antonini L, Sabatino M, Sapienza F, Baldini E, Buzzi R, Vertuani S, Manfredini S. Ragno A, et al. Among authors: antonini l. Molecules. 2021 Oct 17;26(20):6279. doi: 10.3390/molecules26206279. Molecules. 2021. PMID: 34684861 Free PMC article.
Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Kurtanović N, Tomašević N, Matić S, Mitrović MM, Kostić DA, Sabatino M, Antonini L, Ragno R, Mladenović M. Kurtanović N, et al. Among authors: antonini l. Eur J Med Chem. 2022 Jan 5;227:113869. doi: 10.1016/j.ejmech.2021.113869. Epub 2021 Sep 29. Eur J Med Chem. 2022. PMID: 34710747
Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules.
Valentini E, D'Aguanno S, Di Martile M, Montesano C, Ferraresi V, Patsilinakos A, Sabatino M, Antonini L, Chiacchiarini M, Valente S, Mai A, Colotti G, Ragno R, Trisciuoglio D, Del Bufalo D. Valentini E, et al. Among authors: antonini l. Theranostics. 2022 Feb 28;12(5):2427-2444. doi: 10.7150/thno.64233. eCollection 2022. Theranostics. 2022. PMID: 35265218 Free PMC article.
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes.
Matutino Bastos T, Botelho Pereira Soares M, Haddad Franco C, Alcântara L, Antonini L, Sabatino M, Mautone N, Holanda Freitas-Junior L, Moraes CB, Ragno R, Rotili D, Schenkman S, Mai A, Silvio Moretti N. Matutino Bastos T, et al. Among authors: antonini l. Int J Mol Sci. 2020 May 22;21(10):3659. doi: 10.3390/ijms21103659. Int J Mol Sci. 2020. PMID: 32455951 Free PMC article.
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.
Nowak RP, Tumber A, Hendrix E, Ansari MSZ, Sabatino M, Antonini L, Andrijes R, Salah E, Mautone N, Pellegrini FR, Simelis K, Kawamura A, Johansson C, Passeri D, Pellicciari R, Ciogli A, Del Bufalo D, Ragno R, Coleman ML, Trisciuoglio D, Mai A, Oppermann U, Schofield CJ, Rotili D. Nowak RP, et al. Among authors: antonini l. J Med Chem. 2021 Dec 9;64(23):17031-17050. doi: 10.1021/acs.jmedchem.1c00605. Epub 2021 Nov 29. J Med Chem. 2021. PMID: 34843649 Free PMC article.
89 results